Literature DB >> 2342801

Glaucoma in oculodermal melanocytosis.

C Teekhasaenee1, R Ritch, U Rutnin, N Leelawongs.   

Abstract

Oculodermal melanocytosis (ODM) is a developmental disorder of the embryonic neural crest involving virtually all of the structures of the eye derived from this tissue. The authors examined 194 previously unreported Thai patients with ODM. Elevated intraocular pressures (IOPs) developed in the ipsilateral eye of 15 patients at initial examination and in 5 others during follow-up, for a total of 10.3% of the patients. Three patients had congenital or late congenital glaucoma, 14 had ocular hypertension or open-angle glaucoma, and 3 had acute angle-closure glaucoma. Five of the patients with open angles had acute pressure rises accompanied by anterior uveitis. Melanocytic hyperpigmentation of the anterior chamber angle was extensive in all patients except those with acute angle-closure glaucoma. There was no consistent correlation between the extent or density of angle pigmentation and the development of elevated IOP. A larger cup-to-disc ratio in the involved eye, presumably congenital, was present in an additional 19 patients. Glaucoma is common in eyes with ODM and may develop at any age. Patients with ODM and initially normal IOP should be examined at regular intervals. Patients with open angles and acutely elevated IOP should be examined carefully for signs of anterior uveitis and treated medically.

Entities:  

Mesh:

Year:  1990        PMID: 2342801     DOI: 10.1016/s0161-6420(90)32540-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 2.  An update on ophthalmological perspectives in oculodermal melanocytosis (Nevus of Ota).

Authors:  Solmaz Abdolrahimzadeh; Damiano Maria Pugi; Priscilla Manni; Clemente Maria Iodice; Federico Di Tizio; Flavia Persechino; Gianluca Scuderi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-19       Impact factor: 3.535

3.  Giant nevus of Ota.

Authors:  Pukhraj Rishi; Ekta Rishi; Deepak Bhojwani
Journal:  Indian J Ophthalmol       Date:  2015-06       Impact factor: 1.848

Review 4.  Lasers and nevus of Ota: a comprehensive review.

Authors:  Vidhi V Shah; Fleta N Bray; Adam S Aldahan; Stephanie Mlacker; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2015-11-12       Impact factor: 3.161

5.  Phakomatosis Pigmentovascularis Associated With Sturge-Weber Syndrome, Ota Nevus, and Congenital Glaucoma.

Authors:  Yangfan Yang; Xiujuan Guo; Jiangang Xu; Yiming Ye; Xiaoan Liu; Minbin Yu
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 6.  A review of the role of ultrasound biomicroscopy in glaucoma associated with rare diseases of the anterior segment.

Authors:  Giuseppe Mannino; Barmak Abdolrahimzadeh; Silvia Calafiore; Gianmario Anselmi; Cristina Mannino; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-07-29

7.  Bilateral Phacomatosis Pigmentovascularis in a Young Male with Developmental Glaucoma and Varicose Veins.

Authors:  Kirti Singh; Sonal Dangda; Ankush Mutreja; Mainak Bhattacharyya; Kirti Jaisingh
Journal:  J Curr Glaucoma Pract       Date:  2018-08-01

Review 8.  Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management.

Authors:  Solmaz Abdolrahimzadeh; Valeria Fameli; Roberto Mollo; Maria Teresa Contestabile; Andrea Perdicchi; Santi Maria Recupero
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

9.  An Orbital Malignant Melanoma Arising in Cellular Blue Nevus in a Patient with Nevus of Ota.

Authors:  Talayesa Buntinx-Krieg; Jie Ouyang; Mont Cartwright
Journal:  Cureus       Date:  2016-07-18

10.  Bilateral Phakomatosis Cesiomarmorata With Ocular Melanocytosis and Secondary Glaucoma.

Authors:  Omar Khan; Gorka Sesma; Ahmad Al Jaloud
Journal:  Cureus       Date:  2022-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.